KDIGO Conversations in Nephrology
KDIGO Conversations in Nephrology delivers high-yield updates on the diagnosis, treatment, and management of kidney disorders, from diabetes to glomerular diseases. With its short and easy-to-engage episodes of 15 to 30 minutes, this podcast series provides the latest news and expert insights on late-breaking clinical trials, novel treatment options, and evidence-based recommendations with point-of-care applications.
1-15 of 22
Proteinuria First: Managing What Matters in FSGS
KDIGO Conversations in NephrologyProteinuria First: Managing What Matters in FSGS
Kirk Campbell, MD
Laura H. Mariani, MD, MS,FASN
The Podocyte Problem: Understanding FSGS
KDIGO Conversations in NephrologyThe Podocyte Problem: Understanding FSGS
Kirk Campbell, MD
Alessia Fornoni, MD, PhD
Challenges of Implementing Evidence-Based Guidance for IgA Nephropathy
KDIGO Conversations in NephrologyChallenges of Implementing Evidence-Based Guidance for IgA Nephropathy
Dana Rizk, MD
Suneel Udani, MD
How I Treat IgA Nephropathy: Lessons From the Case Files
KDIGO Conversations in NephrologyHow I Treat IgA Nephropathy: Lessons From the Case Files
Dana Rizk, MD
Gaia Coppock, MD
Andrew Lazar, MD
Management of patients with APOL1 Kidney Disease
KDIGO Conversations in NephrologyManagement of patients with APOL1 Kidney Disease
Kirk Campbell, MD
Barry Freedman, MD
Burden and pathophysiology of APOL1 kidney disease
KDIGO Conversations in NephrologyBurden and pathophysiology of APOL1 kidney disease
Kirk Campbell, MD
Bessie Young, MPH, MD
- advertisement
APOL1 Screening and Early Detection: Patient and Clinician Perspectives
KDIGO Conversations in NephrologyAPOL1 Screening and Early Detection: Patient and Clinician Perspectives
Kirk Campbell, MD
Joshua Albright
Titilayo Ilori, MBBS
Overview of the Latest Guidance in IgA Nephropathy Management
KDIGO Conversations in NephrologyOverview of the Latest Guidance in IgA Nephropathy Management
Dana Rizk, MD
Brad Rovin, MD
Treatment Revolution in IgA Nephropathy
KDIGO Conversations in NephrologyTreatment Revolution in IgA Nephropathy
Shikha Wadhwani, MD
Dana Rizk, MD
Personalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI
KDIGO Conversations in NephrologyPersonalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI
Kathleen Liu MD, PhD, FASN, BRCU
Kianoush B. Kashani MD, MS, MSc, FASN, FCCP
Stratifying the Risk of Persistent AKI and Clinical Practice
KDIGO Conversations in NephrologyStratifying the Risk of Persistent AKI and Clinical Practice
Kathleen Liu MD, PhD, FASN, BRCU
Jay L. Koyner, MD
Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
KDIGO Conversations in NephrologyExtracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
Kathleen Liu MD, PhD, FASN, BRCU
Professor Claudio Ronco
- advertisement
Peter Lin MD, CCFP
Sri Lekha Tummalapalli, MD, MBA, MAS
Peter Lin MD, CCFP
Magdalena Madero, MD
Peter Lin MD, CCFP
Joel Topf, MD
